Skip to main content
OpenTrials
Completed

NCT Number: NCT02492724

Activ C European Multicenter Study

Patients are candidates for single-level Artificial Disc Replacement between C3 and C7 who suffer from cervical symptomatic degenerative disc disease. A maximum of 200 cases will be enrolled into the study. An 18-month recruitment period is planned with a 4-year postoperative follow-up period for each subject. Thus, it is anticipated that the study will require a minimum of 5.5 years. Patients will be assessed preoperatively, intraoperatively, prior to discharge and again at 6 weeks, 6 months, 1 year, 2 years and 4 years postoperatively from the date of surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Regional Hospital Liberec, Liberec, Czechia

Loading trial locations.

About this study

The activ C Disc Prosthesis pursues the goal of restoring the disc function, the geometry and motion of the cervical disc. Its concept is based on a ball and socket joint, anchored between adjacent vertebral bodies. The modular prosthesis comprises the following elements: an inferior CoCr plate component anchored in the endplate of the caudal vertebral body. The UHMWPE inlay is securely fixed in this inferior component. The second element is the superior CoCr component, which is anchored in the end plate of the cranial vertebral body. It forms a ball joint with the inlay of the inferior plate component.

The activ C product range enables reconstruction of various disc heights as well as adaptation to the end plate sizes. Secure primary anchorage of the prosthesis to the vertebral bodies is achieved by convexly shaped superior end pla tes and fixation means (spikes and grooves on the superior end plate, a small keel on the inferior end plate), whereas secondary stability is facilitated by an osseointegrative Plasmapore® coating.

The objective of the study is to collect outcome information on the Activ® C Disc Prosthesis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Symptomatic single-level cervical degenerative disc disease with neck and/or arm
  • pain and/or neurological deficit, confirmed by MR scan
  • Single-level surgery and single-level implantation of prosthesis between C3 and C7
  • Age between 18 - 65 years at the time of surgery
  • Pre-operative disc space height of the segment to be operated of at least 3mm
  • Unsuccessful adequate conservative treatment
  • Patient understands the conditions of the study and is willing and able to comply with the post-operative scheduled clinical and radiographic evaluations and the prescribed rehabilitation
  • Patient signed Informed Consent

Exclusion criteria

  • Major facet joint degeneration at the segment to be operated on
  • Severe spondylosis at the segment to be operated on (bridging osteophytes, absence of motion (<2°))
  • Pre-operative disc space height of the segment to be operated on of less than 3mm
  • Major cervical segmental instability at the segment to be operated on (translation ≥3,5 mm and/or ≥11° of rotational difference to that of either adjacent level)
  • Previous trauma to the segment to be operated on resulting in compression or bursting

Treatment and study plan

Primary outcomes

  1. Clinical Outcome measured by the Neck Disability Index (NDI)

    Time frame: 4 years

    The primary endpoint of the study will be changes in the clinical outcome measured by the Neck Disability Index (NDI) as published by Vernon et. al.

Secondary outcomes

  1. Visual Analogue Scale (VAS) on severity of neck pain and arm pain (experienced in the pain-dominant arm)

    Time frame: 4 years

  2. Visual Analogue Scale (VAS) on frequency of neck pain and arm pain (experienced in the pain-dominant arm)

    Time frame: 4 years

  3. Adjacent segment degeneration

    Time frame: 4 years

  4. Postoperative angular motion on flexion/extension radiographs in the replaced segment

    Time frame: 4 years

  5. Complication rates (device related and non-device related)

    Time frame: 4 years

  6. Overall success rate

    Time frame: 4 years

Sponsors and collaborators

Lead sponsor

Aesculap AG

Industry

Registry information

Official study title

Activ C Disc Prosthesis European Multi-Center Clinical Investigation

Important dates

Study start
2007
Primary completion
2009
Study completion
2013
First posted
Jul 9, 2015
Registry last updated
Jul 9, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.